Trademark Search  /  NEWPORT PREMIUM

NEWPORT PREMIUM

○ Dead · Cancelled

U.S. federal trademark · Serial No. 77567413 · Reg. No. 4067563

Mark
NEWPORT PREMIUM
Status
Cancelled
Serial Number
77567413
Registration No.
4067563
Filing Date
September 11, 2008
Registration Date
December 6, 2011
Class(es)
Class 035, Class 042, Class 045

Owners

CAMELOT UK BIDCO LIMITED
78 · LONDON, GB
THOMSON REUTERS CANADA LIMITED
03 · TORONTO, CA
Thomson Reuters (Scientific) Inc.
03 · Philadelphia, PA, US
Thomson Reuters (Scientific) Inc.
03 · Philadelphia, PA, US
Thomson Reuters (Scientific) Inc.
03 · Philadelphia, PA, US

Goods & Services

Providing online computer databases featuring information in the field of pharmaceutical product evaluation; providing online computer databases featuring product information in the field of pharmaceutical active ingredients to pharmaceutical companies for scientific research purposes and product development

Providing business intelligence services, namely, providing online computer databases featuring competitive business intelligence on pharmaceutical companies and pharmaceutical sales; providing online databases featuring information on the creation of marketing tools designed to increase a client company's knowledge of its competitors' products and services, pricing and sales strategy, for use in the field of pharmaceutical product targeting; providing online databases featuring information on new regulatory filings and approvals, namely, business information management featuring information on the status of regulatory submissions made by competitors

Providing online databases featuring information in the field of licensing of pharmaceuticals; providing online databases featuring information in the field of pharmaceutical patent licensing

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NEWPORT PREMIUM" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.